Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia

Infection and Immunity

Volumn 75, Issue 1, 2007, Pages 201-210

  Awandare, Gordon A ^a,b,c   Ouma, Yamo ^b   Ouma, Collins ^b   Were, Tom ^b   Otieno, Richard ^b   Keller, Christopher C ^d   Davenport, Gregory C ^a   Hittner, James B ^e   Vulule, John ^f   Ferrell, Robert ^a   Ong'echa, John M ^b   Perkins, Douglas J ^a,b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF GHANA   (Ghana)

^d LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^e School of Business   (United States)

^f KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOZOIN; MACROPHAGE MIGRATION INHIBITION FACTOR; PIGMENT;

ANEMIA; APOPTOSIS; ARTICLE; BACTEREMIA; CORRELATION ANALYSIS; DISEASE SEVERITY; ERYTHROPOIESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFANT; INFLAMMATION; INNATE IMMUNITY; KENYA; LEUKOCYTE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MONOCYTE; MULTIVARIATE ANALYSIS; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PIGMENT CONTAINING MONOCYTE; PLASMODIUM FALCIPARUM; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETICULOCYTE; SEVERE MALARIAL ANEMIA;

EID: 33845968517     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01327-06     Document Type: Article

References (71)

1. Abdalla, S. H. 1990. Hematopoiesis in human malaria. Blood Cells 16:401-419.
2. Akpede, G. O., and R. M. Sykes. 1993. Malaria with bacteraemia in acutely febrile preschool children without localizing signs: coincidence or association/complication? J. Trop. Med. Hyg. 96:146-150.
3. Alourfi, Z., R. P. Denn, A. Stevens, A. Berry, A. McMaster, and D. W. Ray. 2005. Glucocorticoids suppress macrophage migration inhibitory factor (MIF) expression in a cell-type-specific manner. J. Mol. Endocrinol. 34:583-595.
4. Amodu, O. K., A. A. Adeyemo, P. E. Olumese, and R. A. Gbadegesin. 1998. Intraleucocytic malaria pigment and clinical severity of malaria in children. Trans. R. Soc. Trop. Med. Hyg. 92:54-56.
5. Arese, P., and E. Schwarzer. 1997. Malarial pigment (haemozoin): a very active 'inert' substance. Ann. Trop. Med. Parasitol. 91:501-516.
6. Awandare, G. A., C. Ouma, C. C. Keller, T. Were, R. Otieno, Y. Ouma, G. C. Davenport, J. B. Hittner, J. M. Ong'echa, R. Ferrell, and D. J. Perkins. 2006. A macrophage migration inhibitory factor promoter polymorphism is associated with high-density parasitemia in children with malaria. Genes Immun. 7:568-575. (First published 24 August 2006; doi:10.1038/sj.gene.6364332.)
7. Awandare, G. A., J. B. Hittner, P. G. Kremsner, D. O. Ochiel, C. C. Keller, J. B. Weinberg, I. A. Clark, and D. J. Perkins. 2006. Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria. Clin. Immunol. 119:219-225.
8. Bacher, M., C. N. Metz, T. Calandra, K. Mayer, J. Chesney, M. Lohoff, D. Gemsa, T. Donnelly, and R. Bucala. 1996. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl. Acad. Sci. USA 93:7849-7854.
9. Beier, J. C., C. N. Oster, F. K. Onyango, J. D. Bales, J. A. Sherwood, P. V. Perkins, D. K. Chumo, D. V. Koech, R. E. Whitmire, C. R. Roberts, et al. 1994. Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. Am. J. Trop. Med. Hyg. 50:529-536.
10. Berkley, J., S. Mwarumba, K. Bramham, B. Lowe, and K. Marsh. 1999. Bacteraemia complicating severe malaria in children. Trans. R. Soc. Trop. Med. Hyg. 93:283-286.
11. Bernhagen, J., T. Calandra, R. A. Mitchell, S. B. Martin, K. J. Tracey, W. Voelter, K. R. Manogue, A. Cerami, and R. Bucala. 1993. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365:756-759.
12. Bozza, M., A. R. Satoskar, G. Lin, B. Lu, A. A. Humbles, C. Gerard, and J. R. David. 1999. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189:341-346.
13. Breman, J. G., A. Egan, and G. T. Keusch. 2001. The intolerable burden of malaria: a new look at the numbers. Am. J. Trop. Med. Hyg. 64:iv-vii.
14. Burchard, G. D., P. Radloff, J. Philipps, M. Nkeyi, J. Knobloch, and P. G. Kremsner. 1995. Increased erythropoietin production in children with severe malarial anemia. Am. J. Trop. Med. Hyg. 53:547-551.
15. Calandra, T., J. Bernhagen, R. A. Mitchell, and R. Bucala. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179:1895-1902.
16. Calandra, T., B. Echtenacher, D. L. Roy, J. Pugin, C. N. Metz, L. Hultner, D. Heumann, D. Mannel, R. Bucala, and M. P. Glauser. 2000. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat. Med. 6:164-170.
17. Calandra, T., and T. Roger. 2003. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3:791-800.
18. Casals-Pascual, C., O. Kai, J. O. Cheung, S. Williams, B. Lowe, M. Nyanoti, T. N. Williams, K. Maitland, M. Molyneux, C. R. Newton, N. Peshu, S. M. Watt, and D. J. Roberts. 2006. Suppression of erythropoiesis in malarial anemia is associated with hemozoin in vitro and in vivo. Blood 108:2569-2577. (First published 27 June 2006; doi:10.1182/blood-2006-05- 018697.)
19. Chaisavaneeyakorn, S., N. Lucchi, C. Abramowsky, C. Othoro, S. C. Chaiyaroj, Y. P. Shi, B. L. Nahlen, D. S. Peterson, J. M. Moore, and V. Udhayakumar. 2005. Immunohistological characterization of macrophage migration inhibitory factor expression in Plasmodium falciparum-infected placentas. Infect. Immun. 73:3287-3293.
20. Chaisavaneeyakorn, S., J. M. Moore, C. Othoro, J. Otieno, S. C. Chaiyaroj, Y. P. Shi, B. L. Nahlen, A. A. Lal, and V. Udhayakumar. 2002. Immunity to placental malaria. IV. Placental malaria is associated with up-regulation of macrophage migration inhibitory factor in intervillous blood. J. Infect. Dis. 186:1371-1375.
21. Chaiyaroj, S. C., A. S. Rutta, K. Muenthaisong, P. Watkins, M. Na Ubol, and S. Looareesuwan. 2004. Reduced levels of transforming growth factor-beta1, interleukin-12 and increased migration inhibitory factor are associated with severe malaria. Acta Trop. 89:319-327.
22. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
23. Clark, I. A., M. M. Awburn, R. O. Whitten, C. G. Harper, N. G. Liomba, M. E. Molyneux, and T. E. Taylor. 2003. Tissue distribution of migration inhibitory factor and inducible nitric oxide synthase in falciparum malaria and sepsis in African children. Malar. J. 2:6.
24. Clark, I. A., and W. B. Cowden. 2003. The pathophysiology of falciparum malaria. Pharmacol. Ther. 99:221-260.
25. Clark, I. A., J. L. Virelizier, E. A. Carswell, and P. R. Wood. 1981. Possible importance of macrophage-derived mediators in acute malaria. Infect. Immun. 32:1058-1066.
26. David, J. R. 1966. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA 56:72-77.
27. Day, N. P., T. D. Pham, T. L. Phan, X. S. Dinh, P. L. Pham, V. C. Ly, T. H. Tran, T. H. Nguyen, D. B. Bethell, H. P. Nguyan, T. H. Tran, and N. J. White. 1996. Clearance kinetics of parasites and pigment-containing leukocytes in severe malaria. Blood 88:4694-4700.
28. Goldie, P., E. F. Roth, Jr., J. Oppenheim, and J. P. Vanderberg. 1990. Biochemical characterization of Plasmodium falciparum hemozoin. Am. J. Trop. Med. Hyg. 43:584-596.
29. Graham, S. M., A. L. Walsh, E. M. Molyneux, A. J. Phiri, and M. E. Molyneux. 2000. Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. Trans. R. Soc. Trop. Med. Hyg. 94:310-314.
30. Isidori, A. M., G. A. Kaltsas, M. Korbonits, M. Pyle, M. Gueorguiev, A. Meinhardt, C. Metz, N. Petrovsky, V. Popovic, R. Bucala, and A. B. Grossman. 2002. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease. 3. Clin. Endocrinol. Metab. 87:1834-1840.
31. Juttner, S., J. Bernhagen, C. N. Metz, M. Rollinghoff, R. Bucala, and A. Gessner. 1998. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. J. Immunol. 161:2383-2390.
32. Keller, C. C., J. B. Hittner, B. K. Nti, J. B. Weinberg, P. G. Kremsner, and D. J. Perkins. 2004. Reduced peripheral PGE2 biosynthesis in Plasmodium falciparum malaria occurs through hemozoin-induced suppression of blood mononuclear cell cyclooxygenase-2 gene expression via an interleukin-10-independent mechanism. Mol. Med. 10:45-54.
33. Keller, C. C., P. G. Kremsner, J. B. Hittner, M. A. Misukonis, J. B. Weinberg, and D. J. Perkins. 2004. Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells. Infect. Immun. 72:4868-4873.
34. Koebernick, H., L. Grode, J. R. David, W. Rohde, M. S. Rolph, H. W. Mittrucker, and S. H. Kaufmann. 2002. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 99:13681-13686.
35. Kurtzhals, J. A., V. Adabayeri, B. Q. Goka, B. D. Akanmori, J. O. Oliver-Commey, F. K. Nkrumah, C. Behr, and L. Hviid. 1998. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351:1768-1772.
36. Kurtzhals, J. A., O. Rodrigues, M. Addae, J. O. Commey, F. K. Nkrumah, and L. Hviid. 1997. Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br. J. Haematol. 97:169-174.
37. Lackritz, E. M., C. C. Campbell, T. K. Ruebush II, A. W. Hightower, W. Wakube, R. W. Steketee, and J. B. Were. 1992. Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet 340:524-528.
38. Luty, A. J., D. J. Perkins, B. Lell, R. Schmidt-Ott, L. G. Lehman, D. Luckner, B. Greve, P. Matousek, K. Herbich, D. Schmid, J. B. Weinberg, and P. G. Kremsner. 2000. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Infect. Immun. 68:3909-3915.
39. Lyke, K. E., D. A. Diallo, A. Dicko, A. Kone, D. Coulibaly, A. Guindo, Y. Cissoko, L. Sangare, S. Coulibaly, B. Dakouo, T. E. Taylor, O. K. Doumbo, and C. V. Plowe. 2003. Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. Am. J. Trop. Med. Hyg. 69:253-259.
40. Marsh, K., and R. W. Snow. 1997. Host-parasite interaction and morbidity in malaria endemic areas. Philos. Trans. R. Soc. Lond. B 352:1385-1394.
41. Martiney, J. A., B. Sherry, C. N. Metz, M. Espinoza, A. S. Ferrer, T. Calandra, H. E. Broxmeyer, and R. Bucala. 2000. Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia. Infect. Immun. 68:2259-2267.
42. McDevitt, M. A., J. Xie, V. Gordeuk, and R. Bucala. 2004. The anemia of malaria infection: role of inflammatory cytokines. Curr. Hematol. Rep. 3:97-106.
43. McDevitt, M. A., J. Xie, G. Shanmugasundaram, J. Griffith, A. Liu, C. McDonald, P. Thuma, V. R. Gordeuk, C. N. Metz, R. Mitchell, J. Keefer, J. David, L. Leng, and R. Bucala. 2006. A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. J. Exp. Med. 203:1185-1196.
44. McElroy, P. D., F. O. ter Kuile, A. A. Lal, P. B. Bloland, W. A. Hawley, A. J. Oloo, A. S. Monto, S. R. Meshnick, B. L. Nahlen, et al. 2000. Effect of Plasmodium falciparum parasitemia density on hemoglobin concentrations among full-term, normal birth weight children in western Kenya, IV. Am. J. Trop. Med. Hyg. 62:504-512.
45. Metzger, W. G., B. G. Mordmuller, and P. G. Kremsner. 1995. Malaria pigment in leucocytes. Trans. R. Soc. Trop. Med. Hyg. 89:637-638.
46. Miller, K. L., J. C. Schooley, K. L. Smith, B. Kullgren, L. J. Mahlmann, and P. H. Silverman. 1989. Inhibition of erythropoiesis by a soluble factor in murine malaria. Exp. Hematol. 17:379-385.
47. Mizue, Y., J. Nishihira, T. Miyazaki, S. Fujiwara, M. Chida, K. Nakamura, K. Kikuchi, and M. Mukai. 2000. Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int. J. Mol. Med. 5:397-403.
48. Nguyen, P. H., N. Day, T. D. Pram, D. J. Ferguson, and N. J. White. 1995. Intraleucocytic malaria pigment and prognosis in severe malaria. Trans. R. Soc. Trop. Med. Hyg. 89:200-204.
49. Nussenblatt, V., G. Mukasa, A. Metzger, G. Ndeezi, E. Garrett, and R. D. Semba. 2001. Anemia and interleukin-10, tumor necrosis factor alpha, and erythropoietin levels among children with acute, uncomplicated Plasmodium falciparum malaria. Clin. Diagn. Lab Immunol. 8:1164-1170.
50. Ochiel, D. O., G. A. Awandare, C. C. Keller, J. B. Hittner, P. Kremsner, J. B. Weinberg, and D. J. Perkins. 2005. Differential regulation of beta-chemokines in children with acute falciparum malaria. Infect. Immun. 73:4190-4197.
51. Ong'echa, J. M., C. C. Keller, T. Were, C. Ouma, R. O. Otieno, Z. Landis-Lewis, D. Ochiel, J. L. Slingluff, S. Mogere, G. A. Ogonji, A. S. Orago, J. M. Vulule, S. S. Kaplan, R. D. Day, and D. J. Perkins. 2006. Parasitemia, anemia, and malarial anemia in infants and young children in a rural holoendemic Plasmodium falciparum transmission area. Am. J. Trop. Med. Hyg. 74:376-385.
52. Othoro, C., A. A. Lal, B. Nahlen, D. Koech, A. S. Orago, and V. Udhayakumar. 1999. A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J. Infect. Dis. 179:279-282.
53. Otieno, R. O., C. Ouma, J. M. Ong'echa, C. C. Keller, T. Were, E. N. Waindi, M. G. Michaels, R. D. Day, J. M. Vulule, and D. J. Perkins. 2006. Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. AIDS 20:275-280.
54. Perkins, D. J., J. M. Moore, J. Otieno, Y. P. Shi, B. L. Nahlen, V. Udhayakumar, and A. A. Lal. 2003. In vivo acquisition of hemozoin by placental blood mononuclear cells suppresses PGE2, TNF-alpha, and 1L-10. Biochem. Biophys. Res. Commun. 311:839-846.
55. Perkins, D. J., J. B. Weinberg, and P. G. Kremsner. 2000. Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity. J. Infect. Dis. 182:988-992.
56. Pichyangkul, S., P. Saengkrai, and H. K. Webster. 1994. Plasmodium falciparum pigment induces monocytes to release high levels of tumor necrosis factor-alpha and interleukin-1 beta. Am. J. Trop. Med. Hyg. 51:430-435.
57. Reyes, J. L., L. I. Terrazas, B. Espinoza, D. Cruz-Robles, V. Soto, I. Rivera-Montoya, L. Gomez-Garcia, H. Snider, A. R. Satoskar, and M. Rodriguez-Sosa. 2006. Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection. Infect. Immun. 74: 3170-3179.
58. Satoskar, A. R., M. Bozza, M. Rodriguez Sosa, G. Lin, and J. R. David. 2001. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect. Immun. 69:906-911.
59. Schwarzer, E., M. Alessio, D. Ulliers, and P. Arese. 1998. Phagocytosis of the malarial pigment, hemozoin, impairs expression of major histocompatibility complex class II antigen, CD54, and CD11c in human monocytes. Infect. Immun. 66:1601-1606.
60. Schwarzer, E., F. Turrini, D. Ulliers, G. Giribaldi, H. Ginsburg, and P. Arese. 1992. Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J Exp. Med. 176:1033-1041.
61. Sherry, B. A., G. Alava, K. J. Tracey, J. Martiney, A. Cerami, and A. F. Slater. 1995. Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1 alpha, and MIP-1 beta) in vitro, and altered thermoregulation in vivo. J. Inflamm. 45:85-96.
62. Silverman, P. H., J. C. Schooley, and L. J. Mahlmann. 1987. Murine malaria decreases hemopoietic stem cells. Blood 69:408-413.
63. Snow, R. W., J. A. Omumho, B. Lowe, C. S. Molyneux, J. O. Obiero, A. Palmer, M. W. Weber, M. Pinder, B. Nahlen, C. Ohonyo, C. Newhold, S. Gupta, and K. Marsh. 1997. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 349:1650-1654.
64. Srichaikul, T., M. Wasanasomsithi, V. Poshyachinda, N. Panikbutr, and T. Rabieb. 1969. Ferrokinetic studies and erythropoiesis in malaria. Arch. Intern. Med. 124:623-628.
65. Weatherall, D., and P. Abdalla. 1982. The anaemia of P. falciparum malaria. Br. Med. Bull. 38:147-151.
66. Weinberg, J. B., J. J. Muscato, and J. E. Niedel. 1981. Monocyte chemotactic peptide receptor. Functional characteristics and ligand-induced regulation. J. Clin. Investig. 68:621-630.
67. Were, T., J. B. Hittner, C. Ouma, R. O. Otieno, A. S. S. Orago, J. M. Ong'echa, J. M. Vulule, C. C. Keller, and D. J. Perkins. 2006. Suppression of RANTES in children with Plasmodium falciparum malaria is associated with severe malarial anemia and suppression of erythropoiesis. Haematologica 91:1396-1399.
68. Wickramasinghe, S. N., and S. H. Abdalla. 2000. Blood and bone marrow changes in malaria. Baillieres Best Pract. Res. Clin. Haematol. 13:277-299.
69. World Health Organization. 2005. World Malaria Report 2005. United Nations Children's Fund, World Health Organization, Geneva, Switzerland. http://www.rollbackmalaria.org/wmr2005/pdf/WMReport_lr.pdf.
70. Xu, D., S. J. McSorley, L. Tetley, S. Chatfield, G. Dougan, W. L. Chan, A. Satoskar, J. R. David, and F. Y. Liew. 1998. Protective effect on Leishmania major infection of migration inhibitory factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella typhimurium. J. Immunol. 160:1285-1289.
71. Yap, G. S., and M. M. Stevenson. 1991. Production of soluble inhibitor of erythropoiesis during Plasmodium chabaudi AS infection in resistant and susceptible mice. Ann. N. Y. Acad. Sci. 628:279-281.